Keyphrases
Prostate Cancer Cells
100%
Cytotoxicity
100%
Docetaxel
100%
Paclitaxel
100%
Caffeic Acid Phenethyl Ester
100%
Estrogen Receptor
42%
Co-treatment
14%
Protein Abundance
14%
PC-3 Cells
14%
LNCaP
14%
PC-3
14%
Selective Estrogen Receptor Modulators
14%
Growth Factors
7%
Tumor Suppressor
7%
Antiproliferative Activity
7%
Phosphorylation
7%
Mechanistic Studies
7%
Cytotoxic Effect
7%
Receptor-interacting Protein Kinase 1 (RIPK1)
7%
Modulatory
7%
Insulin-like
7%
B-cell Lymphoma 2 (Bcl-2)
7%
Cyclin D1 (CCND1)
7%
C-Myc
7%
Treatment Group
7%
Caspase-3 Activity
7%
P27Kip1
7%
Combined Treatment
7%
Akt Phosphorylation
7%
Forkhead Box O1 (FOXO1)
7%
A1 Receptor
7%
DNA Ploidy Analysis
7%
DU145
7%
Synergistic Interaction
7%
Beneficial Role
7%
Caspase-3 Protein
7%
Combination Index
7%
Apoptotic Effect
7%
Propolis
7%
Prostate Disease
7%
Activity Abundance
7%
Chemomodulation
7%
Index Calculation
7%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Cytotoxicity
100%
Docetaxel
100%
Paclitaxel
100%
Caffeic Acid Phenethyl Ester
100%
Estrogen Receptor
42%
Selective Estrogen Receptor Modulator
14%
Tumor Suppressor Protein
7%
Receptor Protein
7%
Caspase 3
7%
Cyclin D1
7%
Synergism
7%
Somatomedin C Receptor
7%
Prostate Disease
7%
Propolis
7%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Estrogen Receptor
100%
Cytotoxicity
100%
LNCaP
25%
Tumor Suppressor Protein
12%
Antiproliferative Activity
12%
Cyclin D1
12%
Insulin-Like Growth Factor 1 Receptor
12%
Bcl-2
12%
Oncogene C Myc
12%
Caspase 3
12%
Ploidy
12%
Propolis
12%